🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-02-15
Trial ID
NCT05103358
Treatments Being Tested
This study will evaluate the safety, MTD and/or RP2D, PK, and clinical acti...
Status
Terminated
Location
Local Institution - 019-104
Start Date
2023-08-07
Trial ID
NCT05840510
Treatments Being Tested
To find a recommended dose of gemcitabine and nab-sirolimus that can be giv...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-08-14
Trial ID
NCT06308419
Treatments Being Tested
The purpose of this study is to determine whether ABI-009 will make advance...
Status
Terminated
Location
Ochsner Clinic Foundation
Start Date
2018-11-05
Trial ID
NCT03670030
Treatments Being Tested
This is a phase 1, multi-center, open-label, dose-escalation study of nab-s...
Status
Recruiting
Location
South Texas Accelerated Research Therapeutics, LLC
Start Date
2022-11-23
Trial ID
NCT05661461
Treatments Being Tested
This single arm phase II study proposes to evaluate the efficacy and safety...
Status
Active Not Recruiting
Location
OU Health Stephenson Cancer Center
Start Date
2024-12-26
Trial ID
NCT06494150
Treatments Being Tested
Purpose of this study is to determine appropriate dosing of ABI-009 and eva...
Status
Completed
Location
Columbia University Medical Center
Start Date
2014-04-09
Trial ID
NCT02009332
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
The goal of this clinical trial is to evaluate the efficacy of investigator...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-09-13
Trial ID
NCT05954442
Treatments Being Tested
This phase I trial studies the side effects and best dose of nanoparticle a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-08-15
Trial ID
NCT02975882